Stephen Liu
MD
Chief of Hematology and Oncology
Georgetown University
Dec 16, 2025
Episode
339
Soundcloud
Share
In this special episode of Lung Cancer Considered, Dr. Narjust Florez and Dr. Stephen Liu discuss highlights from the IASLC | ASCO 2025 North America Conference on Lung Cancer.
Dr. Igor Odintsov discusses updates in diagnostic pathology, including the integration of next-generation sequencing into the patient's journey. Dr. Byoung Chul Cho shares data from the phase 3 trial of gotistobart vs. docetaxel in patients with metastatic squamous cell lung cancer. Dr. Sulin Wu shares insights on the role of family history in lung cancer among women and low-exposure smokers.
Guest
Narjust Florez
MD
Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Byoung Chul Cho
MD, PhD
Professor, Division of Medical Oncology
Yonsei University College of Medicine
Yonsei Cancer Center
Igor Odintsov
Instructor, Harvard Medical School
Associate Pathologist, Brigham and Women’s Hospital
Sulin Wu
MD, PhD, ABMGG Diplomate
Fellow, Section of Hematology and Oncology
Department of Medicine, University of Chicago
